Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.

1,622.29 16.75 −1.02%
Market cap
$32.8B
P/E
36.4×
Fwd P/E
25.5×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

30.52 33.01 29.50 28.68
P/S ratio
6.39 7.14 6.26 6.22
P/FCF ratio
28.28 33.86 32.23 29.75
P/Operating CF
84.11 127.38 183.02 82.81
P/B ratio
0.00 0.00 0.00 2,004.62
EV/Sales
6.93 7.65 6.79 6.72
EV/EBITDA
22.17 24.77 22.13 21.27
EV/FCF
30.68 36.32 34.96 32.14
Current Ratio
1.07 1.14 1.20 1.12
Net Debt/EBITDA
6.64 5.54 8.36 5.93
Debt/Equity
(8.87) (91.05) (53.21) 164.70
Earnings Yield
3.28% 3.03% 3.39% 3.49%
Free Cash Flow Yield
3.54% 2.95% 3.10% 3.36%
Free Cash Flow per Share
13.40 8.93 6.03 14.05
Book value per Share
(12.15) (1.15) (2.06) 0.64
Free Cash Flow
274.88 184.08 122.38 282.62
EV/EBIT
24.64 27.55 24.66 23.65
Other line items

Show all line items

Columns are period end dates